
Residency Essentials: Oncology 3
Oncology 3 (IR oncology therapies)
The objective of the Oncology 3 course is to build on the topics learned in Oncology 1 & 2 and demonstrate firm understanding of the options and role of IR in oncologic treatment by scoring greater than 85% in the post course quiz.
Expected completion time: 4 hours
Learning Objectives
- Review the different modalities for locoregional therapies for oncology
- Learn the mechanisms, advantages, disadvantages, and current treatment applications for each locoregional modality.
- Understand how to select patients appropriate for locoregional therapy
Course Developers:
- Francis G. Celii, MD- MD Anderson / UT Houston
- Armeen Mahvash , MD- MD Anderson
- Nicolas J. Cardenas, MD- MD Anderson
- Joshua D. Kuban, MD- MD Anderson / UT Houston

Facebook
X
LinkedIn
Forward